Marshall Wace
EVH icon

Marshall Wace’s Evolent Health EVH Stock Holding History

Marshall Wace’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5M Buy
3,413,245
+2,628,233
+335% +$10.1M 0.01% 763
2026
Q1 		$1.79M Buy
785,012
+539,458
+220% +$1.71M ﹤0.01% 1846
2025
Q4 		$982K Sell
245,554
-409,193
-62% -$2.27M ﹤0.01% 1946
2025
Q3 		$5.54M Buy
654,747
+627,968
+2,345% +$6.09M 0.01% 1147
2025
Q2 		$302K Buy
26,779
+729
+3% +$6.7K ﹤0.01% 2321
2025
Q1 		$247K Sell
26,050
-68,270
-72% -$690K ﹤0.01% 2334
2024
Q4 		$1.06M Buy
94,320
+29,328
+45% +$515K ﹤0.01% 1705
2024
Q3 		$1.84M Buy
64,992
+584
+0.9% +$15.1K ﹤0.01% 1401
2024
Q2 		$1.23M Buy
+64,408
New +$1.64M ﹤0.01% 1595
2023
Q1 		– Sell
-81,950
Closed -$2.3M – 2786
2022
Q4 		$2.3M Sell
81,950
-281,790
-77% -$8.08M 0.01% 1648
2022
Q3 		$13.1M Sell
363,740
-59,995
-14% -$2.11M 0.03% 687
2022
Q2 		$13M Buy
423,735
+59,705
+16% +$1.74M 0.03% 693
2022
Q1 		$11.8M Buy
364,030
+134,134
+58% +$3.51M 0.02% 773
2021
Q4 		$6.36M Buy
229,896
+187,347
+440% +$5.37M 0.01% 1182
2021
Q3 		$1.32M Buy
+42,549
New +$1.02M 0.01% 1832
2019
Q4 		– Sell
-419,855
Closed -$3.02M – 1797
2019
Q3 		$3.02M Sell
419,855
-1,193,417
-74% -$8.56M 0.02% 643
2019
Q2 		$12.8M Buy
1,613,272
+844,888
+110% +$10M 0.11% 220
2019
Q1 		$9.67M Buy
+768,384
New +$12.2M 0.09% 270
2018
Q3 		– Sell
-52,623
Closed -$1.11M – 1174
2018
Q2 		$1.11M Buy
+52,623
New +$996K 0.02% 499
2016
Q4 		– Sell
-80,099
Closed -$1.97M – 1007
2016
Q3 		$1.97M Buy
+80,099
New +$1.87M 0.01% 600

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace's EVH Position: Q2 2026 in Review

Marshall Wace increased its Evolent Health (EVH) stake by 335% in Q2 2026, buying an estimated $10.1M and bringing the position to 3,413,245 shares worth $18.5M. The position accounts for 0.01% of the portfolio, ranked #763.

Marshall Wace first reported a position in EVH in Q3 2016 and has held it in 20 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Marshall Wace held 3,413,245 shares of Evolent Health worth $18.5M as of Q2 2026.
  • Marshall Wace bought 2,628,233 Evolent Health shares in Q2 2026, an estimated $10.1M.
  • Evolent Health made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #763 holding.
  • Marshall Wace first reported a position in Evolent Health in Q3 2016 and has held it in 20 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.